RT Journal Article
SR Electronic
T1 Multimodal surveillance of SARS-CoV-2 at a university enables development of a robust outbreak response framework
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.07.06.22277314
DO 10.1101/2022.07.06.22277314
A1 Brittany A. Petros
A1 Jillian S. Paull
A1 Christopher H. Tomkins-Tinch
A1 Bryn C. Loftness
A1 Katherine C. DeRuff
A1 Parvathy Nair
A1 Gabrielle L. Gionet
A1 Aaron Benz
A1 Taylor Brock-Fisher
A1 Michael Hughes
A1 Leonid Yurkovetskiy
A1 Shandukani Mulaudzi
A1 Emma Leenerman
A1 Thomas Nyalile
A1 Gage K. Moreno
A1 Ivan Specht
A1 Kian Sani
A1 Gordon Adams
A1 Simone V. Babet
A1 Emily Baron
A1 Jesse T. Blank
A1 Chloe Boehm
A1 Yolanda Botti-Lodovico
A1 Jeremy Brown
A1 Adam R. Buisker
A1 Timothy Burcham
A1 Lily Chylek
A1 Paul Cronan
A1 Valentine Desreumaux
A1 Megan Doss
A1 Belinda Flynn
A1 Adrianne Gladden-Young
A1 Olivia Glennon
A1 Hunter D. Harmon
A1 Thomas V. Hook
A1 Anton Kary
A1 Clay King
A1 Christine Loreth
A1 Libby Marrs
A1 Kyle J. McQuade
A1 Thorsen T. Milton
A1 Jada M. Mulford
A1 Kyle Oba
A1 Leah Pearlman
A1 Mark Schifferli
A1 Madelyn J. Schmidt
A1 Grace M. Tandus
A1 Andy Tyler
A1 Megan E. Vodzak
A1 Kelly Krohn Bevill
A1 Andres Colubri
A1 Bronwyn L. MacInnis
A1 A. Zeynep Ozsoy
A1 Eric Parrie
A1 Kari Sholtes
A1 Katherine J. Siddle
A1 Ben Fry
A1 Jeremy Luban
A1 Daniel J. Park
A1 John Marshall
A1 Amy Bronson
A1 Stephen F. Schaffner
A1 Pardis C. Sabeti
YR 2022
UL http://medrxiv.org/content/early/2022/07/07/2022.07.06.22277314.abstract
AB Universities are particularly vulnerable to infectious disease outbreaks and are also ideal environments to study transmission dynamics and evaluate mitigation and surveillance measures when outbreaks occur. Here, we introduce a SARS-CoV-2 surveillance and response framework based on high-resolution, multimodal data collected during the 2020-2021 academic year at Colorado Mesa University. We analyzed epidemiological and sociobehavioral data (demographics, contact tracing, and wifi-based co-location data) alongside pathogen surveillance data (wastewater, random, and reflexive diagnostic testing; and viral genomic sequencing of wastewater and clinical specimens) to characterize outbreak dynamics and inform policy decisions. We quantified group attributes that increased disease risk, and highlighted parallels between traditional and wifi-based contact tracing. We additionally used clinical and environmental viral sequencing to identify cryptic transmission, cluster overdispersion, and novel lineages or mutations. Ultimately, we used distinct data types to identify information that may help shape institutional policy and to develop a model of pathogen surveillance suitable for the future of outbreak preparedness.Competing Interest StatementP.C.S. is a co-founder of, shareholder in, and scientific advisor to Sherlock Biosciences, Inc; she is also a Board member of and shareholder in Danaher Corporation. P.C.S. has filed IP related to genome sequencing and analysis. Funding StatementThis work was supported by the National Science Foundation (NSF) Graduate Research Fellowship Program to J.S.P. (grant number 1745303), and C.H.T-T. (grant number 1745303); the Hertz Foundation to J.S.P.; the National Institute of General Medical Sciences to B.A.P. (grant number T32GM007753); the National Science Foundation (NSF) to B.C.L. (grant number 2046440); the Moore Foundation to B.C.L., the National Institute of Allergy and Infectious Diseases to B.C.L. (grant number 2U19AI110818) and to P.C.S. (grant number U19AI110818 and U01AI151812); the National Institutes of Health to J.L. (grant numbers R37AI147868 and R01AI148784); the Massachusetts Consortium on Pathogen Readiness to J.L.; the Centers for Disease Control and Prevention (CDC) COVID-19 baseline genomic surveillance contract to the Clinical Research Sequencing Platform (grant number 75D30121C10501) and a CDC Broad Agency Announcement to B.L.M. (grant number 75D30120C09605); and the Howard Hughes Medical Institute to P.C.S. This work was made possible by support from the Flu laboratory and a cohort of generous donors through the TED Audacious Project, including the ELMA Foundation, MacKenzie Scott, Skoll Foundation and Open Philanthropy. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board of Massachusetts Institute of Technology gave ethical approval for this work. The Institutional Review Board of the Western IRB-Copernicus Group (WCG) gave ethical approval for this work. The study was conducted at the Broad Institute with approval from the MIT Institutional Review Board under Protocol #1612793224 and from WCG IRB Protocol #20210166 under Protocol: Investigating Viral Emergence and Spread in Community Settings. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll non-identifiable data produced in the present work are contained in the manuscript. Genomic sequences were deposited in NCBI GenBank, GISAID, and the Sequence Read Archive, as applicable. https://github.com/broadinstitute/sc2-cmu-study